Clinical Trial Update: Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 trial updating efficacy and safety of pomalidomide plus dexamethasone in relapsed/refractory multiple myeloma with renal insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED